InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,528.93
(
-2.12%
)
US TECH 100
18,455.60
(
-3.12%
)
Dow Jones
40,936.93
(
-1.51%
)
Brent Oil
73.62
(
-4.62%
)
Bitcoin
57,981.12
(
-1.93%
)
Post# of 428655
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bravo33

Send PM Follow Ignore
Followers 0
Posts 64
Boards Moderated 0
Alias Born 11/28/2012

bravo33

Re: None

Friday, 06/21/2013 9:59:00 AM

Friday, June 21, 2013 9:59:00 AM

Post# of 428655
Amarin Announces Positive Results of Phase 1 Clinical Trial Measuring the Bioavailability of a Fixed-Dose Combo
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM

UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM

Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM

Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM

ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM

North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!